Search research articles
Contact Us
Filters
Showing results (481-490 of 1,011) with videos related to
Page
of 102
Sort By:
Clinical Pharmacology and Therapeutics
|
January 3, 2013
Inclusion of pediatric samples in an opt-out biorepository linking DNA to de-identified medical records: pediatric BioVU
T L McGregor, S L Van Driest, K B Brothers, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
November 9, 2000
Hormonal and metabolic counterregulation during and after high-dose insulin-induced hypoglycemia in diabetes mellitus type 2
M G Bischof, C Ludwig, A Hofer, et al.
Circulation
|
May 1, 1989
Stereoselective disposition and pharmacologic activity of propafenone enantiomers
H K Kroemer, C Funck-Brentano, D J Silberstein, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP
|
March 24, 2021
Evidence for Pharmacogenomic Effects on Risperidone Outcomes in Pediatrics
Katelyn M Rossow, Kazeem A Oshikoya, Ida T Aka, et al.
Diabetologia
|
February 24, 2001
Lipid-dependent control of hepatic glycogen stores in healthy humans
H Stingl, M Krssák, M Krebs, et al.
Circulation Research
|
September 17, 2011
Cardiovascular pharmacogenomics
Dan M Roden, Julie A Johnson, Stephen E Kimmel, et al.
Diabetologia
|
February 23, 1999
Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study
M Krssak, K Falk Petersen, A Dresner, et al.
Genesis (New York, N.Y. : 2000)
|
November 4, 2006
Recombinase-mediated cassette exchange to rapidly and efficiently generate mice with human cardiac sodium channels
Kai Liu, Susan Hipkens, Tao Yang, et al.
Pharmacogenetics and Genomics
|
July 20, 2010
Genome-wide association studies in pharmacogenomics: successes and lessons
Alison A Motsinger-Reif, Eric Jorgenson, Mary V Relling, et al.
Diabetes, Obesity & Metabolism
|
April 12, 2013
Effects of pioglitazone versus glimepiride exposure on hepatocellular fat content in type 2 diabetes
E Phielix, A Brehm, E Bernroider, et al.
Page
of 102
Search research articles
Search
Showing results (481-490 of 1,011) with videos related to
Sort By:
Page
of 102
Clinical Pharmacology and Therapeutics
|
January 3, 2013
Inclusion of pediatric samples in an opt-out biorepository linking DNA to de-identified medical records: pediatric BioVU
T L McGregor, S L Van Driest, K B Brothers, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
November 9, 2000
Hormonal and metabolic counterregulation during and after high-dose insulin-induced hypoglycemia in diabetes mellitus type 2
M G Bischof, C Ludwig, A Hofer, et al.
Circulation
|
May 1, 1989
Stereoselective disposition and pharmacologic activity of propafenone enantiomers
H K Kroemer, C Funck-Brentano, D J Silberstein, et al.
Journal of Developmental and Behavioral Pediatrics : JDBP
|
March 24, 2021
Evidence for Pharmacogenomic Effects on Risperidone Outcomes in Pediatrics
Katelyn M Rossow, Kazeem A Oshikoya, Ida T Aka, et al.
Diabetologia
|
February 24, 2001
Lipid-dependent control of hepatic glycogen stores in healthy humans
H Stingl, M Krssák, M Krebs, et al.
Circulation Research
|
September 17, 2011
Cardiovascular pharmacogenomics
Dan M Roden, Julie A Johnson, Stephen E Kimmel, et al.
Diabetologia
|
February 23, 1999
Intramyocellular lipid concentrations are correlated with insulin sensitivity in humans: a 1H NMR spectroscopy study
M Krssak, K Falk Petersen, A Dresner, et al.
Genesis (New York, N.Y. : 2000)
|
November 4, 2006
Recombinase-mediated cassette exchange to rapidly and efficiently generate mice with human cardiac sodium channels
Kai Liu, Susan Hipkens, Tao Yang, et al.
Pharmacogenetics and Genomics
|
July 20, 2010
Genome-wide association studies in pharmacogenomics: successes and lessons
Alison A Motsinger-Reif, Eric Jorgenson, Mary V Relling, et al.
Diabetes, Obesity & Metabolism
|
April 12, 2013
Effects of pioglitazone versus glimepiride exposure on hepatocellular fat content in type 2 diabetes
E Phielix, A Brehm, E Bernroider, et al.
Page
of 102